Skip
  • ENG
  • PL
  • About us
  • COVID-19 in Poland
  • Data sources
  • Tools & Services
  • R&D Projects
  • COVID-19 vaccines in Poland
  • News
  • About us
  • COVID-19 in Poland
  • Data sources
  • Tools & Services
  • R&D Projects
  • COVID-19 vaccines in Poland
  • News

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

  • by pcss
  • 12 June 20207 June 2021

Lekarz w kitlu trzymający w dłoniach strzykawkę wypełnioną płynem.

First promising results regarding the Covid-19 vaccine. The results published in The Lancet.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31208-3/fulltext

ENG
PL ENG